消化指南

订阅

MedSci主页 / 所有栏目 / 消化指南

晚期胰腺癌介入治疗临床操作指南（试行）（第六版）

2022-04-13 中国癌症研究基金会介入医学委员会 临床放射学杂志

消化道肿瘤介入治疗晚期胰腺癌

一晚期胰腺癌的定义胰腺癌是常见消化系统恶性肿瘤之一。它在最常见癌症中排名第14位，也是目前世界范围内癌症死亡的第7大原因。根据Globocan最新的统计预测，2020年大约有466000例患者死于胰腺

中文标题：

晚期胰腺癌介入治疗临床操作指南（试行）（第六版）

发布机构：

中国癌症研究基金会介入医学委员会

发布日期：

2022-04-13

简要介绍：

一晚期胰腺癌的定义胰腺癌是常见消化系统恶性肿瘤之一。它在最常见癌症中排名第14位，也是目前世界范围内癌症死亡的第7大原因。根据Globocan最新的统计预测，2020年大约有466000例患者死于胰腺癌。胰腺癌的也常适用AJCC的TNM分期，如表1所示：临床上多用是否可以手术切除对胰腺癌进行分期：可切除胰腺癌，交界性可切除胰腺癌（可能手术切除，也可能不能手术切除）、局部晚期胰腺癌（不可手术切除）、转移性/晚期胰腺癌（不可手术切除）。所有诊断出来的胰腺癌中，只有不到15%是可能手术的，85%以上都不可手术切除。 

相关资料下载：
[AttachmentFileName(sort=1, fileName=晚期胰腺癌介入治疗临床操作指南（试行）（第六版）.pdf)] GetToolGuiderByIdResponse(projectId=1, id=4481b1c002a2086d, title=晚期胰腺癌介入治疗临床操作指南（试行）（第六版）, enTitle=, guiderFrom=临床放射学杂志, authorId=0, author=, summary=一晚期胰腺癌的定义胰腺癌是常见消化系统恶性肿瘤之一。它在最常见癌症中排名第14位，也是目前世界范围内癌症死亡的第7大原因。根据Globocan最新的统计预测，2020年大约有466000例患者死于胰腺, cover=https://img.medsci.cn/20220425/1650876432173_5579292.png, journalId=0, articlesId=null, associationId=1335, associationName=中国癌症研究基金会介入医学委员会, associationIntro=, copyright=0, guiderPublishedTime=Wed Apr 13 00:00:00 CST 2022, originalUrl=, linkOutUrl=, content=<p><span style="color: #666666;">一晚期胰腺癌的定义胰腺癌是常见消化系统恶性肿瘤之一。它在最常见癌症中排名第14位，也是目前世界范围内癌症死亡的第7大原因</span><span style="color: #666666;">。根据Globocan最新的统计预测，2020年大约有466000例患者死于胰腺癌</span><span style="color: #666666;">。胰腺癌的也常适用AJCC的TNM分期，如表1所示：临床上多用是否可以手术切除对胰腺癌进行分期：可切除胰腺癌，交界性可切除胰腺癌（可能手术切除，也可能不能手术切除）、局部晚期胰腺癌（不可手术切除）、转移性/晚期胰腺癌（不可手术切除）。所有诊断出来的胰腺癌中，只有不到15%是可能手术的，85%以上都不可手术切除。&nbsp;</span></p>, tagList=[TagDto(tagId=439, tagName=消化道肿瘤), TagDto(tagId=445, tagName=介入治疗), TagDto(tagId=5032, tagName=晚期胰腺癌)], categoryList=[CategoryDto(categoryId=4, categoryName=消化, tenant=100), CategoryDto(categoryId=5, categoryName=肿瘤, tenant=100), CategoryDto(categoryId=23, categoryName=普通外科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=25467, appHits=139, showAppHits=0, pcHits=336, showPcHits=25328, likes=2, shares=23, comments=5, approvalStatus=1, publishedTime=Tue Apr 26 15:45:00 CST 2022, publishedTimeString=2022-04-13, pcVisible=1, appVisible=1, editorId=0, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=FUNNYMAN, createdTime=Mon Apr 25 16:49:30 CST 2022, updatedBy=5579292, updatedName=FUNNYMAN, updatedTime=Sat Jan 06 15:14:11 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=晚期胰腺癌介入治疗临床操作指南（试行）（第六版）.pdf)])
晚期胰腺癌介入治疗临床操作指南（试行）（第六版）.pdf
下载请点击：
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1216513, encodeId=831a12165139e, content=<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8ba6319857, createdName=1064510_1039, createdTime=Tue May 03 09:47:52 CST 2022, time=2022-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215903, encodeId=c29612159030a, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=718a8143613, createdName=ms6000000660915726, createdTime=Sat Apr 30 22:59:20 CST 2022, time=2022-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215116, encodeId=851d1215116af, content=是一种有效治疗手段, beContent=null, objectType=guider, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eouShoVRPZvFshog2V4Bs8JhDIybaiaNUp16CYicwfDeRB6KoOUPj3fibYhRSsWDJ2LGJM8fFQVIrdnQ/132, createdBy=f44f2325690, createdName=苏新攀, createdTime=Wed Apr 27 20:38:07 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215011, encodeId=2b52121501145, content=***, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=330c8114473, createdName=ms6000000067978801, createdTime=Wed Apr 27 13:04:02 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214949, encodeId=434e1214949ea, content=<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8ba6319857, createdName=1064510_1039, createdTime=Wed Apr 27 08:10:31 CST 2022, time=2022-04-27, status=1, ipAttribution=)]
    2022-05-03 1064510_1039

    #肿瘤#好

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1216513, encodeId=831a12165139e, content=<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8ba6319857, createdName=1064510_1039, createdTime=Tue May 03 09:47:52 CST 2022, time=2022-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215903, encodeId=c29612159030a, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=718a8143613, createdName=ms6000000660915726, createdTime=Sat Apr 30 22:59:20 CST 2022, time=2022-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215116, encodeId=851d1215116af, content=是一种有效治疗手段, beContent=null, objectType=guider, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eouShoVRPZvFshog2V4Bs8JhDIybaiaNUp16CYicwfDeRB6KoOUPj3fibYhRSsWDJ2LGJM8fFQVIrdnQ/132, createdBy=f44f2325690, createdName=苏新攀, createdTime=Wed Apr 27 20:38:07 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215011, encodeId=2b52121501145, content=***, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=330c8114473, createdName=ms6000000067978801, createdTime=Wed Apr 27 13:04:02 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214949, encodeId=434e1214949ea, content=<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8ba6319857, createdName=1064510_1039, createdTime=Wed Apr 27 08:10:31 CST 2022, time=2022-04-27, status=1, ipAttribution=)]
    2022-04-30 ms6000000660915726

    学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1216513, encodeId=831a12165139e, content=<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8ba6319857, createdName=1064510_1039, createdTime=Tue May 03 09:47:52 CST 2022, time=2022-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215903, encodeId=c29612159030a, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=718a8143613, createdName=ms6000000660915726, createdTime=Sat Apr 30 22:59:20 CST 2022, time=2022-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215116, encodeId=851d1215116af, content=是一种有效治疗手段, beContent=null, objectType=guider, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eouShoVRPZvFshog2V4Bs8JhDIybaiaNUp16CYicwfDeRB6KoOUPj3fibYhRSsWDJ2LGJM8fFQVIrdnQ/132, createdBy=f44f2325690, createdName=苏新攀, createdTime=Wed Apr 27 20:38:07 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215011, encodeId=2b52121501145, content=***, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=330c8114473, createdName=ms6000000067978801, createdTime=Wed Apr 27 13:04:02 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214949, encodeId=434e1214949ea, content=<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8ba6319857, createdName=1064510_1039, createdTime=Wed Apr 27 08:10:31 CST 2022, time=2022-04-27, status=1, ipAttribution=)]
    2022-04-27 苏新攀

    是一种有效治疗手段

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1216513, encodeId=831a12165139e, content=<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8ba6319857, createdName=1064510_1039, createdTime=Tue May 03 09:47:52 CST 2022, time=2022-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215903, encodeId=c29612159030a, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=718a8143613, createdName=ms6000000660915726, createdTime=Sat Apr 30 22:59:20 CST 2022, time=2022-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215116, encodeId=851d1215116af, content=是一种有效治疗手段, beContent=null, objectType=guider, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eouShoVRPZvFshog2V4Bs8JhDIybaiaNUp16CYicwfDeRB6KoOUPj3fibYhRSsWDJ2LGJM8fFQVIrdnQ/132, createdBy=f44f2325690, createdName=苏新攀, createdTime=Wed Apr 27 20:38:07 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215011, encodeId=2b52121501145, content=***, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=330c8114473, createdName=ms6000000067978801, createdTime=Wed Apr 27 13:04:02 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214949, encodeId=434e1214949ea, content=<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8ba6319857, createdName=1064510_1039, createdTime=Wed Apr 27 08:10:31 CST 2022, time=2022-04-27, status=1, ipAttribution=)]
    2022-04-27 ms6000000067978801

    ***

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1216513, encodeId=831a12165139e, content=<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8ba6319857, createdName=1064510_1039, createdTime=Tue May 03 09:47:52 CST 2022, time=2022-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215903, encodeId=c29612159030a, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=718a8143613, createdName=ms6000000660915726, createdTime=Sat Apr 30 22:59:20 CST 2022, time=2022-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215116, encodeId=851d1215116af, content=是一种有效治疗手段, beContent=null, objectType=guider, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eouShoVRPZvFshog2V4Bs8JhDIybaiaNUp16CYicwfDeRB6KoOUPj3fibYhRSsWDJ2LGJM8fFQVIrdnQ/132, createdBy=f44f2325690, createdName=苏新攀, createdTime=Wed Apr 27 20:38:07 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215011, encodeId=2b52121501145, content=***, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=330c8114473, createdName=ms6000000067978801, createdTime=Wed Apr 27 13:04:02 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214949, encodeId=434e1214949ea, content=<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8ba6319857, createdName=1064510_1039, createdTime=Wed Apr 27 08:10:31 CST 2022, time=2022-04-27, status=1, ipAttribution=)]
    2022-04-27 1064510_1039

    #肿瘤#

    0

相关指南

食管癌诊疗指南 （2022年版）

国家癌症中心 · 2022-04-11

胰腺癌诊疗指南 （2022年版）

国家癌症中心 · 2022-04-11

胃癌诊疗指南 （2022年版）

国家癌症中心 · 2022-04-11

中国恶性肿瘤整合诊治指南-结肠癌部分

中国抗癌协会(Chinese Anti-cancer Association) · 2022-02-25

2021版CSCO胃癌诊疗指南转移性胃癌更新解读

中山大学肿瘤防治中心肿瘤内科 · 2022-03-28

食管癌术后良性吻合口狭窄的治疗共识

中国医院协会介入医学中心分会 · 2022-02-25